Chlorpropamide-induced water retention in patients with diabetes mellitus.
D000368:Aged; D002747:Chlorpropamide / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced* / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology; D008297:Male; D014042:Tolazamide / Q000627:therapeutic use; D014667:Vasopressins / Q000378:metabolism; D014869:Water Intoxication / Q000139:chemically induced* / Q000503:physiopathology
D014667:Vasopressins; D014042:Tolazamide; D002747:Chlorpropamide